Guideline compliance and outcomes of genetic testing in pancreatic cancer patients.

被引：0
|
作者：
Klatte, Derk C. F.
Hardway, Heather D.
Starr, Jason S.
Riegert-Johnson, Douglas L.
Clift, Kristin E.
Potjer, Thomas P.
van Leerdam, Monique E.
Presutti, R. John
Wallace, Michael B.
Bi, Yan
机构：
[1] Mayo Clin, Jacksonville, FL USA
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
688
引用
收藏
页码：688 / 688
页数：1
相关论文
共 50 条
  • [21] Uptake in genetic testing in patients with pancreatic cancer with oncologist-driven testing protocol.
    King, Traci
    Widick, Page
    Paredes, Rodrigo
    Klein, Oliver
    Krejdovsky, Jill
    Tung, Nadine M.
    Peters, Mary Linton Bounetheau
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 33 - 33
  • [22] Expanding access to genetic testing for pancreatic cancer
    Rodriguez, Nicolette Juliana
    Syngal, Sapna
    FAMILIAL CANCER, 2024, 23 (03) : 247 - 254
  • [23] Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome
    Samadder, N. Jewel
    Riegert-Johnson, Douglas
    Boardman, Lisa
    Rhodes, Deborah
    Wick, Myra
    Okuno, Scott
    Kunze, Katie L.
    Golafshar, Michael
    Uson, Pedro L. S., Jr.
    Mountjoy, Luke
    Ertz-Archambault, Natalie
    Patel, Neej
    Rodriguez, Eduardo A.
    Lizaola-Mayo, Blanca
    Lehrer, Michael
    Thorpe, Cameron S.
    Yu, Nathan Y.
    Esplin, Edward D.
    Nussbaum, Robert L.
    Sharp, Richard R.
    Azevedo, Cindy
    Klint, Margaret
    Hager, Megan
    Macklin-Mantia, Sarah
    Bryce, Alan H.
    Bekaii-Saab, Tanios S.
    Sekulic, Aleksandar
    Stewart, Keith A.
    JAMA ONCOLOGY, 2021, 7 (02) : 230 - 237
  • [24] Desire for and use of genetic testing in a population-based sample of breast cancer patients.
    Hawley, Sarah T.
    Hamilton, Ann S.
    Graff, John
    Katz, Steven J.
    Jagsi, Reshma
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Lymphocyte-to-monocyte ratio for predicting gemcitabine containing chemotherapy outcomes in pancreatic cancer patients.
    Wang, Liwei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Differences in patterns of care and outcomes of elderly versus younger metastatic pancreatic cancer (mPC) patients.
    Vijayvergia, Namrata
    Dotan, Efrat
    Devarajan, Karthik
    Hatahet, Kamel
    Rahman, Farah
    Cohen, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Molecular testing for prostate cancer in Greek patients.
    Liontos, Michael
    Kunadis, Elena
    Svarna, Anna
    Skafida, Efthymia
    Fiste, Oraianthi
    Markellos, Christos
    Zakopoulou, Roubini
    Papatheodoridi, Alkistis
    Andrikopoulou, Angeliki
    Kaparelou, Maria
    Koutsoukos, Konstantinos
    Zagouri, Flora
    Dimopoulos, Meletios A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [28] Multigene hereditary cancer testing in sarcoma patients.
    Jackson, Sarah A.
    Baxter, Melanie D.
    Mester, Jessica
    Susswein, Lisa
    Marshall, Megan L.
    Hruska, Kathleen S.
    Klein, Rachel T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Compliance to adjuvant endocrine therapy and survival in breast cancer patients.
    Chamalidou, Chaido
    Nasic, Salmir
    Linderholm, Barbro
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 35
  • [30] Outcomes of Universal Point-of-Care Genetic Testing in Diverse Patients With Pancreatic Ductal Adenocarcinoma
    Drogan, Christine M.
    Kindler, Hedy L.
    Gao, Guimin
    Kupfer, Sonia S.
    JCO PRECISION ONCOLOGY, 2023, 7
12345